New drug approvals hit 21-year high in 2017
U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light -- more than double the previous year -- while the figure also rose in the European Union.
Tuesday, January 2, 2018
New drug approvals hit 21-year high in 2017
New drug approvals hit 21-year high in 2017
U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light -- more than double the previous year -- while the figure also rose in the European Union.
Related Posts:
0 comments:
Post a Comment